Effect of atrial fibrillation on atrial refractoriness in humans.
about
The role of action potential alternans in the initiation of atrial fibrillation in humans: a review and future directionsSymptoms In Atrial Fibrillation: A Contemporary Review And Future DirectionsBachmann's bundle: does it play a role in atrial fibrillation?Acute pressure overload cardiac arrhythmias are dependent on the presence of myocardial tissue catecholaminesEffects of pretreatment with verapamil on early recurrences after electrical cardioversion of persistent atrial fibrillation: a randomised study.Effects of 17beta-estradiol on tachycardia-induced changes of atrial refractoriness and cisapride-induced ventricular arrhythmiaSinus Node Dysfunction and Atrial Fibrillation: A Reversible Phenomenon?Non-invasive characterisation of coronary lesion morphology by multi-slice computed tomography: a promising new technology for risk stratification of patients with coronary artery diseasePrediction of sinus rhythm maintenance following DC-cardioversion of persistent atrial fibrillation - the role of atrial cycle length.Optimal management of the patient with an episode of atrial fibrillation in and out of the hospital: acute cardioversion or not?Radiofrequency catheter ablation of atrial fibrillation initiated by pulmonary vein ectopic beats.Multistage electrotherapy delivered through chronically-implanted leads terminates atrial fibrillation with lower energy than a single biphasic shock.Tachycardia induced changes of atrial electrophysiological properties.Atrial pacing for the prevention and termination of atrial fibrillation.Present treatment options for atrial fibrillationHeart failure and atrial fibrillation: from basic science to clinical practiceAtrial fibrillation in patients with congestive heart failure.Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by intravenous sotalol.Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters.Sinus rhythm maintenance following DC cardioversion of atrial fibrillation is not improved by temporary precardioversion treatment with oral verapamil.Atrial remodelling in atrial fibrillation: CaMKII as a nodal proarrhythmic signalAbsence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF).Electrophysiological abnormalities in patients with paroxysmal atrial fibrillation in the absence of overt structural heart disease.Effects of IKur blocker MK-0448 on human right atrial action potentials from patients in sinus rhythm and in permanent atrial fibrillationPhysiologic and pathophysiologic role of calpain: implications for the occurrence of atrial fibrillation.Biomarkers in atrial fibrillation: a clinical review.Biomarkers in atrial fibrillation: an overview.Atrial metabolism and tissue perfusion as determinants of electrical and structural remodelling in atrial fibrillation.Cryoablation of atrial fibrillation.Atrial Calpains: Mediators of Atrialmyopathies in Atrial Fibrillation.Early Cardioversion in Atrial Fibrillation: Earlier Is Better, but Not Always and (Maybe) Not Immediately.Atrial Remodeling And Atrial Fibrillation: Mechanistic Interactions And Clinical Implications.Patients with persistent atrial fibrillation taking oral verapamil exhibit a lower atrial frequency on the ECG.Electrophysiological properties of the fibrillating atrium: implications for therapy.The seventh annual Gordon K. Moe Lecture. Atrial fibrillation: from cell t bedside.Age-dependent atrial arrhythmic phenotype secondary to mitochondrial dysfunction in Pgc-1β deficient murine hearts.Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).Transient appearance of antegrade conduction via an AV accessory pathway caused by atrial fibrillation in a patient with intermittent Wolff-Parkinson-White syndrome.Mitochondrial DNA deletion associated with the reduction of adenine nucleotides in human atrium and atrial fibrillation.Effect of verapamil on prevention of atrial fibrillation in patients implanted with an implantable atrial defibrillator.
P2860
Q26822583-93CC53CB-0389-4EFB-AF1A-EA3D37E27AF7Q28070025-3AB03517-E5F1-44B8-A9A6-60DEFDE33F14Q28267641-CED96A5D-3381-47CD-8018-8F657F1A1FE2Q28362668-057A2FCC-D8FC-41DB-9F5F-C44FED1AEA75Q28362672-001C67B1-56C8-43B3-A0A2-53195CD076F5Q28377348-9CEFEE02-38C3-4BCD-B1F5-676182097B22Q30238620-2902B945-2856-4BBF-A173-117F6C3C64E4Q30542175-7858E05C-1AD6-4BC6-8E0F-AF0AE17BB8ACQ33236262-0D7C476B-2932-497C-8B69-683F5FAE86A8Q33597985-5567656C-FB62-43C4-828F-FA3C25BCD657Q33858302-FB87B8AD-72AA-467E-88EE-FF7F17AA7338Q34008059-18296919-0312-48DD-97D6-763FECC4BC9EQ34153802-E71F974D-13C6-4E7D-96E3-5E23D4564788Q34989748-94CA04F5-4113-4518-814A-7ECA1163E12BQ35075598-5B3B9044-EF57-4184-8716-398403FF05C1Q35138993-61F7623E-E579-4BF7-A639-4186904546E9Q35197762-AA3A68A4-BBA2-4519-AB72-0B359C64080FQ35373532-7ED966DB-ADB7-4C20-B74D-CCC9B545B53AQ35579908-78132F08-D96D-4150-92DD-36CC6C3EB5B1Q35582341-7D7C2E11-087E-4855-A0AD-7C7AA9DD5C05Q36650585-97D55B74-1FA4-4FC4-AC50-BCFBF8A819E9Q37098363-AA2206FE-9438-4A39-A10B-DE63910A1908Q37496884-C912CA5F-1478-48B4-91CB-E2843F19EA7AQ37614642-B8B24D8E-F458-4DFC-9AFE-5CBC268D7BF1Q37812402-C701918D-DE92-4754-8D33-8CA952753542Q38079565-BB9FCBC6-8295-426C-8D06-7D1F1CD61C82Q38174213-C318B9A9-CDA8-413A-8428-4AA5B324BE64Q38703115-505170FC-F090-46E8-A4E5-27BF708486C2Q38991912-337C948F-8C18-41C0-8357-43DB8A1E5EB7Q39036936-37BC83FA-CCF1-4E13-94F9-19EB9641477BQ39097180-4A4AA196-87D4-42A1-B2A9-88C5D8E7128FQ39300430-8E664C38-D53E-4336-9E35-869E26DE21F2Q39604839-623A0D94-2F15-4698-A11C-17DB6D18E31EQ40856806-394AB831-B7D4-4FD7-8595-9703A18E0BDEQ41568510-544F9C18-C24F-40D7-9A46-F608A5E08E1EQ42650117-598FDE2E-BDF9-46FF-A37D-8213F06A9B29Q42923039-86F434FE-5DE3-4596-97DD-7F87F3A26829Q43037991-2056ACAA-E4B4-41B1-841F-E08BE7923B82Q43650903-61C272E9-7CF9-4EE7-B4E9-2B3FB717777DQ43671891-E07106D9-FA01-4ED9-9164-1C51CB5CF687
P2860
Effect of atrial fibrillation on atrial refractoriness in humans.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Effect of atrial fibrillation on atrial refractoriness in humans.
@en
Effect of atrial fibrillation on atrial refractoriness in humans.
@nl
type
label
Effect of atrial fibrillation on atrial refractoriness in humans.
@en
Effect of atrial fibrillation on atrial refractoriness in humans.
@nl
prefLabel
Effect of atrial fibrillation on atrial refractoriness in humans.
@en
Effect of atrial fibrillation on atrial refractoriness in humans.
@nl
P2093
P356
P1433
P1476
Effect of atrial fibrillation on atrial refractoriness in humans.
@en
P2093
Strickberger SA
P304
P356
10.1161/01.CIR.94.7.1600
P407
P577
1996-10-01T00:00:00Z